April 9, 2025: Healey Platform Trial Examines Pridopidine in ALS, in This Week’s PCT Grand Rounds

Headshot of Dr. Jeremy ShefnerIn this Friday’s PCT Grand Rounds, Jeremy Shefner of the Barrow Neurological Institute will present “A Phase 2 Trial of Pridopidine in ALS, Studied as a Regimen With the Healey Platform Trial.”

The Grand Rounds session will be held on Friday, April 11, 2025, at 1:00 pm eastern.

Shefner is a professor of neurology at the Barrow Neurological Institute in Phoenix, Arizona.

Join the online meeting.